tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Stomach Ulcer D013276 75 associated lipids
Alzheimer Disease D000544 76 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Atherosclerosis D050197 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Seizures D012640 87 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Brain Ischemia D002545 89 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Lechner A et al. Designed biosynthesis of 36-methyl-FK506 by polyketide precursor pathway engineering. 2013 ACS Synth Biol pmid:23654255
Ogasawara K et al. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients. 2013 Clin Pharmacokinet pmid:23633119
Wu SW et al. Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients. 2013 Swiss Med Wkly pmid:23986367
Yagi Y et al. Tacrolimus monotherapy: a promising option for ocular myasthenia gravis. 2013 Eur. Neurol. pmid:23549260
Morgan RE et al. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. 2013 Toxicol. Sci. pmid:23956101
Liu F et al. FK506-binding protein 12 ligands: a patent review. 2013 Expert Opin Ther Pat pmid:23957229
González-Guerrero C et al. Calcineurin inhibitors recruit protein kinases JAK2 and JNK, TLR signaling and the UPR to activate NF-κB-mediated inflammatory responses in kidney tubular cells. 2013 Toxicol. Appl. Pharmacol. pmid:23958496
Picard N The pharmacokinetic interaction between mycophenolic acid and cyclosporine revisited: a commentary on "Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus". 2013 Xenobiotica pmid:23339626
Tanaka E and Yamanaka H [DMARDs (disease-modifying antirheumatic drugs)]. 2013 Nippon Rinsho pmid:23961667
de Jonge H and Kuypers DR Response to "pretransplantation pharmacokinetic assessments to predict posttransplantation dosing requirements in renal transplant recipients: what is known?". 2013 Clin. Pharmacol. Ther. pmid:23340478
Risseeuw MD et al. A "clickable" MTX reagent as a practical tool for profiling small-molecule-intracellular target interactions via MASPIT. 2013 ChemMedChem pmid:23341183
Ren H et al. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial. 2013 Am. J. Nephrol. pmid:23343906
Konofaos P and Terzis JK FK506 and nerve regeneration: past, present, and future. 2013 J Reconstr Microsurg pmid:23322540
Cardet JC and Boyce JA Addition of mycophenolate mofetil to tacrolimus is associated with decreases in food-specific IgE levels in a pediatric patient with liver transplantation-associated food allergy. 2013 J Allergy Clin Immunol Pract pmid:24229832
Shilbayeh S et al. The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients. 2013 Saudi J Kidney Dis Transpl pmid:24231473
Borro JM et al. Long-term success of combined kidney-lung transplantation in a patient with cystic fibrosis. 2013 Arch. Bronconeumol. pmid:23427867
Legris T et al. Humoral immunity after kidney transplantation: impact of two randomized immunosuppressive protocols. 2013 Ann. Transplant. pmid:24231646
Takahara S et al. Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation. 2013 Clin. Exp. Nephrol. pmid:23430390
Kueppers P et al. Functional impact of a single mutation within the transmembrane domain of the multidrug ABC transporter Pdr5. 2013 Biochemistry pmid:23464591
Herranz M et al. Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison. 2013 Eur. J. Clin. Pharmacol. pmid:23196824
Michel M et al. Protein phosphatase-dependent circadian regulation of intermediate-term associative memory. 2013 J. Neurosci. pmid:23467376
Grigoriu S et al. The molecular mechanism of substrate engagement and immunosuppressant inhibition of calcineurin. 2013 PLoS Biol. pmid:23468591
Frassetto L et al. Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients. 2013 Biopharm Drug Dispos pmid:24030928
Sugiura K et al. Cutaneous lupus mucinosis successfully treated with systemic corticosteroid and systemic tacrolimus combination therapy. 2013 J. Am. Acad. Dermatol. pmid:24034403
Verhave JC et al. Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome. 2013 Neth J Med pmid:24038559
Lee SC et al. Calcineurin plays key roles in the dimorphic transition and virulence of the human pathogenic zygomycete Mucor circinelloides. 2013 PLoS Pathog. pmid:24039585
Muthukumar T et al. HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. 2013 Transplantation pmid:23503504
Nakamura T et al. Co-stimulation with bone morphogenetic protein-9 and FK506 induces remarkable osteoblastic differentiation in rat dedifferentiated fat cells. 2013 Biochem. Biophys. Res. Commun. pmid:24064349
Manojlovic Z et al. Tacrolimus (FK506) prevents early stages of ethanol induced hepatic fibrosis by targeting LARP6 dependent mechanism of collagen synthesis. 2013 PLoS ONE pmid:23755290
Wu X et al. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation. 2013 Drug Des Devel Ther pmid:23403805
van Gorp S et al. Amelioration of motor/sensory dysfunction and spasticity in a rat model of acute lumbar spinal cord injury by human neural stem cell transplantation. 2013 Stem Cell Res Ther pmid:23710605
Lee Y et al. Long-term follow-up of de novo allergy in pediatric liver transplantation--10 yr experience of a single center. 2013 Pediatr Transplant pmid:23405954
Pereira MJ et al. The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. 2013 Mol. Cell. Endocrinol. pmid:23160140
Thongprasom K et al. Novel therapies for oral lichen planus. 2013 J. Oral Pathol. Med. pmid:23668304
Kyriakou A et al. Treatment of male genital lichen sclerosus with clobetasol propionate and maintenance with either methylprednisolone aceponate or tacrolimus: a retrospective study. 2013 J Dermatolog Treat pmid:23472631
Lee SE et al. Differential effects of topical corticosteroid and calcineurin inhibitor on the epidermal tight junction. 2013 Exp. Dermatol. pmid:23174045
Sadilkova K et al. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS. 2013 Clin. Chim. Acta pmid:23473895
Saliba F et al. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients. 2013 Med. Mycol. pmid:22800082
Manthripragada AD et al. Off-label topical calcineurin inhibitor use in children. 2013 Pediatrics pmid:24127469
Almazrooa SA et al. Characterization and management of exfoliative cheilitis: a single-center experience. 2013 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:24237731
Reddy KR and Everson GT Treatment of chronic hepatitis C with protease inhibitor-based therapy after liver transplantation. 2013 Hepatology pmid:23908010
Sy SK et al. A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation. 2013 AAPS J pmid:23990505
Goldust M et al. Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs. tacrolimus 0.03% cream. 2013 Ann Parasitol pmid:24171300
Sun W et al. Rapid identification of antifungal compounds against Exserohilum rostratum using high throughput drug repurposing screens. 2013 PLoS ONE pmid:23990907
Chen D et al. Novel single nucleotide polymorphisms in interleukin 6 affect tacrolimus metabolism in liver transplant patients. 2013 PLoS ONE pmid:23991193
Tortorici MA et al. The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteers. 2013 Eur. J. Clin. Pharmacol. pmid:23052408
Annunziato RA et al. Strangers headed to a strange land? A pilot study of using a transition coordinator to improve transfer from pediatric to adult services. 2013 J. Pediatr. pmid:23993138
Schold JD The burden of proof in the design of early phase clinical trials. 2013 Am. J. Transplant. pmid:23802723
Mo S et al. Application of a combined approach involving classical random mutagenesis and metabolic engineering to enhance FK506 production in Streptomyces sp. RM7011. 2013 Appl. Microbiol. Biotechnol. pmid:23053074
Mok CC et al. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study. 2013 Lupus pmid:23995863
Chisholm-Burns MA et al. Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. 2013 Am. J. Transplant. pmid:23819827
Sen A et al. Acute brachial neuritis with central pontine and extrapontine myelinolysis in a renal transplant recipient. 2013 Neurol. Sci. pmid:23820960
Cavallucci V et al. Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease. 2013 Neuromolecular Med. pmid:23821337
Sartori-Valinotti JC et al. A 10-year review of otic lichen planus: the Mayo Clinic experience. 2013 JAMA Dermatol pmid:23824252
Stefos GC et al. NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect. 2013 PLoS ONE pmid:23825664
Martinez NJ et al. The co-chaperones Fkbp4/5 control Argonaute2 expression and facilitate RISC assembly. 2013 RNA pmid:24049110
Hengge UR [Off-label indications for topical tacrolimus]. 2013 Hautarzt pmid:24150824
Choi JY and Kwon OJ Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants? 2013 Transplant. Proc. pmid:24156999
Isoherranen K et al. [Skin problems in a swollen lower limb]. 2013 Duodecim pmid:24159716
Onumah N and Kircik L Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference. 2013 J Drugs Dermatol pmid:24085050
Yoshimura K et al. Successful treatment with 308-nm monochromatic excimer light and subsequent tacrolimus 0.03% ointment in refractory plasma cell cheilitis. 2013 J. Dermatol. pmid:23621817
Kang KY et al. Tacrolimus treatment increases bone formation in patients with rheumatoid arthritis. 2013 Rheumatol. Int. pmid:22447331
Sato H et al. Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid. 2013 Mod Rheumatol pmid:22447556
Wang Y et al. Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control. 2013 J. Med. Chem. pmid:23647266
Goyal RK et al. Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation. 2013 Biol. Blood Marrow Transplant. pmid:23266742
Lee JT et al. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus. 2013 J. Surg. Res. pmid:23566442
Gerich ME et al. Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's disease. 2013 Inflamm. Bowel Dis. pmid:23518805
O'Connell PJ et al. Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. 2013 Am. J. Transplant. pmid:23668890
Monroe JR Progressive changes in facial pigmentation. 2013 JAAPA pmid:23520799
Russ GR et al. Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results. 2013 Am. J. Transplant. pmid:23668931
Jeong JH et al. Effects of surface camouflaged islet transplantation on pathophysiological progression in a db/db type 2 diabetic mouse model. 2013 Biochem. Biophys. Res. Commun. pmid:23523788
von Suesskind-Schwendi M et al. Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus. 2013 Biomed. Pharmacother. pmid:23669280
Hickey MD et al. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. 2013 Liver Transpl. pmid:23526600
Cadou A et al. The Kin1 kinase and the calcineurin phosphatase cooperate to link actin ring assembly and septum synthesis in fission yeast. 2013 Biol. Cell pmid:23294323
Pulzer A et al. Calcineurin inhibitor dose-finding before kidney transplantation in HIV patients. 2013 Transpl. Int. pmid:23227980
Rath T Tacrolimus in transplant rejection. 2013 Expert Opin Pharmacother pmid:23228138
Linnert M et al. The FKBP-type domain of the human aryl hydrocarbon receptor-interacting protein reveals an unusual Hsp90 interaction. 2013 Biochemistry pmid:23418784
Grabczewska Z et al. Neither cyclosporine nor tacrolimus deteriorate endothelial function in renal transplant recipients assessed with reactive hyperernia index. 2013 Transplant. Proc. pmid:23726621
Supavekin S et al. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome. 2013 J Med Assoc Thai pmid:23720975
Ban YH et al. Mutational biosynthesis of a FK506 analogue containing a non-natural starter unit. 2013 Mol Biosyst pmid:23223556
Renner FC et al. The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects. 2013 Transplant. Proc. pmid:23726630
Uni M et al. Successful allogeneic stem cell transplantation for Lennert lymphoma. 2013 Ann. Hematol. pmid:23224245
De Simone P et al. End of the line for sirolimus in liver transplant recipients with hepatitis C virus? 2013 Liver Transpl. pmid:23225519
Arai Y et al. Syndrome of inappropriate antidiuretic hormone secretion induced by tacrolimus following allogeneic cord blood transplantation. 2013 Intern. Med. pmid:23728560
Khuu T et al. Pomegranate-containing products and tacrolimus: a potential interaction. 2013 J. Heart Lung Transplant. pmid:23200637
Penninga L et al. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. 2013 Cochrane Database Syst Rev pmid:23728681
Caplan AL Ensuring the future of uterine transplantation. 2013 Fertil. Steril. pmid:23200690
Rostaing L et al. Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial. 2013 Am. J. Transplant. pmid:23730730
Schaefer B et al. Bleeding complications in pediatric ABO-incompatible kidney transplantation. 2013 Pediatr. Nephrol. pmid:22961637
Patel CG et al. Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus. 2013 Xenobiotica pmid:22934787
Ciancio G et al. A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab. 2013 Transplantation pmid:23903014
Wang Z et al. L-Cysteine promotes the proliferation and differentiation of neural stem cells via the CBS/Hâ‚‚S pathway. 2013 Neuroscience pmid:23376738
Cantisani C et al. Generalized morphea successfully treated with tacrolimus 0.1% ointment. 2013 J Drugs Dermatol pmid:23377321
Herbst S et al. A new and clinically relevant murine model of solid-organ transplant aspergillosis. 2013 Dis Model Mech pmid:23264562
Mattox AR et al. New-onset vitiligo during long-term, stable infliximab treatment of pityriasis rubra pilaris. 2013 J Drugs Dermatol pmid:23377397
Millán O et al. Intracellular IFN-γ and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients. 2013 Cytokine pmid:23265966
Elens L et al. The CYP3A4*22 allele affects the predictive value of a pharmacogenetic algorithm predicting tacrolimus predose concentrations. 2013 Br J Clin Pharmacol pmid:23163400
Qin XL et al. Effect of long-term co-administration of Wuzhi tablet (Schisandra sphenanthera extract) and prednisone on the pharmacokinetics of tacrolimus. 2013 Phytomedicine pmid:23267661
Borio S et al. Proliferative and necrotising otitis externa in a cat without pinnal involvement: video-otoscopic features. 2013 J. Feline Med. Surg. pmid:23197497
Kovermann M and Balbach J Dynamic control of the prolyl isomerase function of the dual-domain SlyD protein. 2013 Biophys. Chem. pmid:23268194